Division of Anesthesiology, Critical Care Medicine.
Division of Multispecialty Adult Anesthesiology, Vanderbilt University Medical Center, Nashville, Tennessee.
Pain Med. 2017 Oct 1;18(10):2013-2026. doi: 10.1093/pm/pnw198.
The primary aim of this study is to determine the effect of adding dexamethasone, clonidine or both with and without epinephrine to ropivacaine and bupivacaine brachial plexus blocks.
Observational study of prospectively collected data.
Single academic outpatient surgery center.
We evaluated 5,515 patient entries who received brachial plexus block (BPB). Multiple, rescue, unsuccessful, and distal nerve blocks of the upper extremity were excluded. The duration was calculated from the time the block was performed until the resolution of the block by patient report. Block durations were compared using Analysis of Variance.
After exclusions, 3,706 nerve blocks were analyzed. The median concentration of ropivacaine used was 0.5%. Both clonidine and dexamethasone significantly increased block duration by 1.1 and 3.0 hours, respectively. Combining clonidine and dexamethasone with ropivacaine increased block duration by 6.2 hours (p<0.001) when compared to ropivacaine alone. Dexamethasone and Clonidine increased block duration by 5.2 hours (p<0.001) when compared to clonidine alone and by 3.2 hours (p<0.001) compared to dexamethasone alone. The addition of epinephrine to any of the adjuvants made no statistically significant difference to the duration of action except when it was added to dexamethasone.
For brachial plexus blocks, epinephrine did not affect the duration of analgesia when added to ropivacaine. Epinephrine did not enhance the observed increase of block duration induced by clonidine or the combination of clonidine and dexamethasone. The most block duration enhancement was observed when combination of clonidine and dexamethasone were added to ropivacaine.
本研究的主要目的是确定在罗哌卡因和布比卡因臂丛阻滞中分别添加地塞米松、可乐定或两者联合,并联合或不联合肾上腺素对阻滞效果的影响。
前瞻性收集数据的观察性研究。
单一家属门诊手术中心。
我们评估了 5515 例接受臂丛神经阻滞(BPB)的患者。排除了多部位、挽救性、不成功和上肢远端神经阻滞。阻滞持续时间从阻滞完成到患者报告阻滞消退的时间计算。使用方差分析比较阻滞持续时间。
排除后,分析了 3706 例神经阻滞。使用的罗哌卡因中位数浓度为 0.5%。可乐定和地塞米松均显著延长阻滞持续时间 1.1 和 3.0 小时,分别。与单独使用罗哌卡因相比,将可乐定和地塞米松与罗哌卡因联合使用可将阻滞持续时间延长 6.2 小时(p<0.001)。与单独使用可乐定相比,地塞米松和可乐定分别延长阻滞持续时间 5.2 小时(p<0.001)和 3.2 小时(p<0.001)。当肾上腺素与任何佐剂联合使用时,除了与地塞米松联合使用外,对作用持续时间没有统计学上的显著影响。
对于臂丛神经阻滞,肾上腺素与罗哌卡因联合使用不影响镇痛持续时间。肾上腺素不能增强可乐定或可乐定和地塞米松联合使用引起的阻滞持续时间的观察到的增加。当将可乐定和地塞米松联合用于罗哌卡因时,观察到的阻滞持续时间延长最大。